Delivery Order SPE2DB22D2218-SPE2DB24FR2ZM

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $3,312.11 firm-fixed-price contract is for the supply of 4,565,364,928 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The award has an ultimate completion date of August 7, 2024. AmerisourceBergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various defense and civilian...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,564,485,940 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The $12,717.66 firm fixed price contract has a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, has a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,440.59 firm-fixed-price contract is for the supply of 4565286529 - TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product. The award has an ultimate completion date of July 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company AmerisourceBergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines. The $3,421.00 contract has a completion date of February 2, 2024. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 indefinite delivery contract with DLA as the primary vehicle for delivering pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,058,855 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The award, valued at $5,904.85, is a firm fixed-price contract with a completion date of January 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and is registered in the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for $4,681.55. The contract is for the supply of 4,565,468,631 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The award has an ultimate completion date of August 16, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the procurement of 4,567,239,883 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The Delivery Order is valued at $28,385.00 and has a firm fixed price pricing type. The contract has a period of performance through February 12, 2025. No set-aside designation was used for this award. AmerisourceBergen Drug Corp is the prime contractor, and this Delivery Order is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The order is for 4,565,393,908 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine and has a firm fixed price of $2,922.98. The award has an ultimate completion date of August 9, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded this contract to supply critical medical commodities...
This is a $11,486.75 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of 4,564,804,496 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,372,782 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The $4,257.62 firm-fixed-price contract has an ultimate completion date of August 8, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide range of essential medical...
  • SPE2DB22D2218
    Indefinite Delivery Contract
  • SPE2DB22D2218-SPE2DB24FR2ZM
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $4,427.26 firm-fixed-price contract is to provide 4,565,260,126 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The delivery order has a completion date of July 29, 2024. The award is not set aside for any specific business category. AmerisourceBergen is a prominent pharmaceutical distributor that has been awarded numerous indefinite delivery contracts by the DLA and other federal agencies to supply a wide range of medical commodities, including prescription drugs, vaccines, and medical supplies, to support military treatment facilities, veterans' healthcare programs, and other government healthcare providers.

Generated 10/25/24, 9:35 AM